CATIS: Immediate reduction in blood pressure demonstrated no benefit in acute stroke

It is shown that hypertension is associated with the occurrence of stroke but immediate treatment for an acute stroke itself is unclear. This study randomized 4071 acute stroke patients enrolled in an anti-hypertensive treatment (systolic pressure reduction by 10-25 % in the first 24 hours) versus control (stopping all antihypertensive drugs). 

The study included patients experiencing stroke within the first 48 hours and had a systolic pressure between 140 and 220 mm Hg without evidence of target organ damage (aortic dissection, myocardial ischemia, etc.) The primary end point was a composite of death and severe disability     (modified Rankin scale ≥ 3 ) at 14 days or at the time of discharge that was similar between the two groups (OR 1.00 , 95% CI 0.88 – 1.14, p = .98 ) . At 3 months the results were also identical between the two groups.

Conclusion:

In patients experiencing an acute stroke immediate reduction in blood pressure compared with the absence of anti-hypertensive treatment did not reduce the incidence of death or severe disability.

Original article

1_jiang_he_slides
Jiang He
2013-11-17

Original title: CATIS trial: Blood Pressure Reduction Among Ischemic Stroke Patients: a Randomized Controlled Clinical Trial

More articles by this author

Mild hypothermia in pre-hospital phase after cardiac arrest

Hypothermia in the hospital phase at 32-34 ° C improves neurological outcome in patients resuscitated after ventricular fibrillation out of the hospital environment. In...

TTM: Hypothermia after cardiac arrest does not offer benefits

Previous studies evaluated therapeutic hypothermia (32 ° C to 34 ° C for 12-24 hours) in patients who remain unconscious after resuscitation from cardiac...

NIAMI: Nitroprusside infusion prior to primary angioplasty

The phenomenon of reperfusion injury is responsible for 50 % of the final infarct size. Several pharmacological and non-pharmacological agents administered before or during...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...